Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05651945 · ClinicalTrials.gov registry record · NA

Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

A NA study of Stroke and Cerebrovascular Accident, sponsored by Hackensack Meridian Health.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05651945 is a NA study of Stroke and Cerebrovascular Accident that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 150 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05651945, a NA study of Stroke and Cerebrovascular Accident, is actively recruiting participants, sponsored by Hackensack Meridian Health.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.

Interventions

  • OTHER Cardiac rehabilitation program

Study Locations (1)

New Jersey

  • Hackensack Meridian Health - JFK Johnson Rehabilitation Institute - Edison

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-01-20
Est. Completion 2031-01-20
Phase NA

Sponsor

Hackensack Meridian Health

90 total trials

What the Registry Record Tells You About NCT05651945

The ClinicalTrials.gov registry entry for NCT05651945 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Cardiac rehabilitation program is the first listed.

NCT05651945 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05651945 about?

NCT05651945 is a clinical study titled "Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)". This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if the...

What is the current status of trial NCT05651945?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-20. Estimated completion is 2031-01-20.

What conditions does trial NCT05651945 study?

This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident.

What interventions are being tested in trial NCT05651945?

The interventions under investigation include: Cardiac rehabilitation program (OTHER).

Who is sponsoring clinical trial NCT05651945?

This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05651945 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.